Medicine and Dentistry
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Virus Nucleocapsid
100%
Disease
40%
Infection
40%
Biological Marker
20%
Odds Ratio
20%
Cross Sectional Study
20%
Symptom
20%
Body Mass Index
20%
Reverse Transcription Polymerase Chain Reaction
20%
Logistic Regression Analysis
20%
Patient Characteristics
20%
Noninvasive Ventilation
20%
Virus Replication
20%
Nose Smear
20%
Nasal Cannula
20%
Remdesivir
20%
Nursing and Health Professions
Severe Acute Respiratory Syndrome
100%
Disease
40%
Hospital Discharge
40%
Clinical Outcome
20%
Body Mass
20%
Odds Ratio
20%
Symptom
20%
Logistic Regression Analysis
20%
Cross-Sectional Study
20%
Infection
20%
Treatment Outcome
20%
Biological Marker
20%
National Health Organization
20%
Noninvasive Ventilation
20%
Reverse Transcription Polymerase Chain Reaction
20%
Nasal Cannula
20%
Remdesivir
20%
Nose Smear
20%
Immunology and Microbiology
Blood Plasma
100%
Virus Nucleocapsid
100%
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Body Mass
5%
Monospecific Antibody
5%
Reverse Transcription Polymerase Chain Reaction
5%
Infectious Disease
5%
Viral Replication
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Disease
40%
Infection
40%
Delta Variant
40%
Symptom
20%
RNA Directed DNA Polymerase
20%
Cross-Sectional Study
20%
Biological Marker
20%
Remdesivir
20%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Body Mass
20%
Cross Sectional Study
20%
Monospecific Antibody
20%
Reverse Transcription Polymerase Chain Reaction
20%
Virus Replication
20%